SAMINA KAJANI: Open Payments
NPI 1548815707 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $110 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 2 | $49 |
| GENZYME CORPORATION | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
| Verona Pharma, Inc. | 1 | $31 |
| Amgen Inc. | 1 | $29 |
| Pulmonx Corporation | 1 | $17 |
| Baxter Healthcare | 1 | $15 |
Products named: Arikayce, DUPIXENT, OFEV, Ohtuvayre, TEZSPIRE, ZEPHYR DELIVERY CATHETER, Hillrom - Vest System Model 105 Home Care.
Industry payments across CA — which companies pay providers there.
